Literature DB >> 10675270

Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines.

M J Robertson1, B T Williams, K Christopherson, Z Brahmi, R Hromas.   

Abstract

Natural killer (NK) cells play an important role in innate and adaptive immune responses to obligate intracellular pathogens. Nevertheless, the regulation of NK cell trafficking and migration to inflammatory sites is poorly understood. Exodus-1/MIP-3alpha/LARC, Exodus-2/6Ckine/SLC, and Exodus-3/MIP-3beta/ELC/CKbeta-11 are CC chemokines that share a unique aspartate-cysteine-cysteine-leucine motif near their amino terminus and preferentially stimulate the migration of T lymphocytes. The effects of Exodus chemokines on human NK cells were examined. Exodus-1, -2, and -3 did not induce detectable chemotaxis of resting peripheral blood NK cells. In contrast, Exodus-2 and -3 stimulated migration of polyclonal activated peripheral blood NK cells in a dose-dependent fashion. Exodus-2 and -3 also induced dose-dependent chemotaxis of NKL, an IL-2-dependent human NK cell line. Results of modified checkerboard assays indicate that migration of NKL cells in response to Exodus-2 and -3 represents true chemotaxis and not simply chemokinesis. Exodus-1, -2, and -3 did not induce NK cell proliferation in the absence of other stimuli. Nevertheless, Exodus-2 and -3 significantly augmented IL-2-induced proliferation of normal human CD56(dim) NK cells. In contrast, Exodus-1, -2, and -3 did not affect the cytolytic activity of resting or activated peripheral blood NK cells. Expression of message for CCR7, a shared receptor for Exodus-2 and -3, was detected in activated polyclonal NK cells and NKL cells but not resting NK cells. Taken together, these results indicate that Exodus-2 and -3 can participate in the recruitment and proliferation of activated NK cells. Exodus-2 and -3 may regulate interactions between T cells and NK cells that are crucial for the generation of optimal immune responses. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675270     DOI: 10.1006/cimm.1999.1601

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  A delay differential equation model for tumor growth.

Authors:  Minaya Villasana; Ami Radunskaya
Journal:  J Math Biol       Date:  2003-05-15       Impact factor: 2.259

2.  Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4.

Authors:  Yong-Hao Hou; Edward F Srour; Heather Ramsey; Richard Dahl; Hal E Broxmeyer; Robert Hromas
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

3.  Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.

Authors:  Melissa A Byers; Psachal A Calloway; Laurie Shannon; Heather D Cunningham; Sarah Smith; Fang Li; Brian C Fassold; Charlotte M Vines
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.

Authors:  Susan J Burke; Michael D Karlstad; Kellie M Regal; Tim E Sparer; Danhong Lu; Carrie M Elks; Ryan W Grant; Jacqueline M Stephens; David H Burk; J Jason Collier
Journal:  Biochim Biophys Acta       Date:  2015-04-13

5.  Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated control.

Authors:  Rutger Luteijn; Gaia Sciaranghella; Jan van Lunzen; Anne Nolting; Anne-Sophie Dugast; Musie S Ghebremichael; Marcus Altfeld; Galit Alter
Journal:  Eur J Immunol       Date:  2011-08-12       Impact factor: 5.532

Review 6.  Does CCL19 act as a double-edged sword in cancer development?

Authors:  Arezoo Gowhari Shabgah; Zaid Mahdi Jaber Al-Obaidi; Heshu Sulaiman Rahman; Walid Kamal Abdelbasset; Wanich Suksatan; Dmitry O Bokov; Lakshmi Thangavelu; Abduladheem Turki Jalil; Farhad Jadidi-Niaragh; Hamed Mohammadi; Kazem Mashayekhi; Jamshid Gholizadeh Navashenaq
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

7.  Transcription factor KLF2 regulates homeostatic NK cell proliferation and survival.

Authors:  Whitney Rabacal; Sudheer K Pabbisetty; Kristen L Hoek; Delphine Cendron; Yin Guo; Damian Maseda; Eric Sebzda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

8.  Identification of human NK17/NK1 cells.

Authors:  Abhilash D Pandya; Zaidoon Al-Jaderi; Rune A Høglund; Trygve Holmøy; Hanne F Harbo; Johannes Norgauer; Azzam A Maghazachi
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

9.  Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model.

Authors:  Yuki Nakamura; Shigeru Miyagawa; Shohei Yoshida; Shigemi Sasawatari; Toshihiko Toyofuku; Koichi Toda; Yoshiki Sawa
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

10.  Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.

Authors:  Davide Corti; Johannes P M Langedijk; Andreas Hinz; Michael S Seaman; Fabrizia Vanzetta; Blanca M Fernandez-Rodriguez; Chiara Silacci; Debora Pinna; David Jarrossay; Sunita Balla-Jhagjhoorsingh; Betty Willems; Maria J Zekveld; Hanna Dreja; Eithne O'Sullivan; Corinna Pade; Chloe Orkin; Simon A Jeffs; David C Montefiori; David Davis; Winfried Weissenhorn; Aine McKnight; Jonathan L Heeney; Federica Sallusto; Quentin J Sattentau; Robin A Weiss; Antonio Lanzavecchia
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.